Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troy A Gatcliffe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 6, 2008
Tumor board: more than treatment planning--a 1-year prospective surveyTroy A Gatcliffe, Robert L Coleman
Obstetrics and Gynecology|May 10, 2003
Vaginal hyperpigmentation due to ochronosisTroy A Gatcliffe, Valena Soto-Wright, John Kasznica
Gynecologic Oncology|March 25, 2014
Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology groupKrishnansu S Tewari, James J Java, Troy A Gatcliffe, et al.
Gynecologic Oncology|November 4, 2008
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancerTroy A Gatcliffe, Krishnansu S Tewari, Amy Shah, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 6, 2008
Tumor board: more than treatment planning--a 1-year prospective surveyTroy A Gatcliffe, Robert L Coleman
Obstetrics and Gynecology|May 10, 2003
Vaginal hyperpigmentation due to ochronosisTroy A Gatcliffe, Valena Soto-Wright, John Kasznica
Gynecologic Oncology|March 25, 2014
Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology groupKrishnansu S Tewari, James J Java, Troy A Gatcliffe, et al.
Gynecologic Oncology|November 4, 2008
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancerTroy A Gatcliffe, Krishnansu S Tewari, Amy Shah, et al.
Pageof 1